DE60117701D1 - Testverfahren für agonisten oder antagonisten der bindung von dynorphin a an den mas-rezeptor - Google Patents
Testverfahren für agonisten oder antagonisten der bindung von dynorphin a an den mas-rezeptorInfo
- Publication number
- DE60117701D1 DE60117701D1 DE60117701T DE60117701T DE60117701D1 DE 60117701 D1 DE60117701 D1 DE 60117701D1 DE 60117701 T DE60117701 T DE 60117701T DE 60117701 T DE60117701 T DE 60117701T DE 60117701 D1 DE60117701 D1 DE 60117701D1
- Authority
- DE
- Germany
- Prior art keywords
- agonists
- antagonists
- binding
- dynorphine
- test procedure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000556 agonist Substances 0.000 title abstract 3
- 239000005557 antagonist Substances 0.000 title abstract 2
- 238000010998 test method Methods 0.000 title 1
- 102400000242 Dynorphin A(1-17) Human genes 0.000 abstract 2
- 108010065372 Dynorphins Proteins 0.000 abstract 2
- 238000003556 assay Methods 0.000 abstract 2
- JMNJYGMAUMANNW-FIXZTSJVSA-N dynorphin a Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 JMNJYGMAUMANNW-FIXZTSJVSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9486—Analgesics, e.g. opiates, aspirine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9406—Neurotransmitters
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/665—Assays involving proteins derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/988—Lyases (4.), e.g. aldolases, heparinase, enolases, fumarase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pathology (AREA)
- Organic Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25797700P | 2000-12-22 | 2000-12-22 | |
| US257977P | 2000-12-22 | ||
| PCT/SE2001/002854 WO2002052267A1 (en) | 2000-12-22 | 2001-12-19 | A method of assaying for agonists or antagonist of dynorphin a binding to the mas receptor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60117701D1 true DE60117701D1 (de) | 2006-05-04 |
| DE60117701T2 DE60117701T2 (de) | 2006-09-21 |
Family
ID=22978581
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60117701T Expired - Fee Related DE60117701T2 (de) | 2000-12-22 | 2001-12-19 | Testverfahren für agonisten oder antagonisten der bindung von dynorphin a an den mas-rezeptor |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7078177B2 (de) |
| EP (1) | EP1346221B1 (de) |
| JP (1) | JP2004516036A (de) |
| AT (1) | ATE320005T1 (de) |
| CA (1) | CA2430719A1 (de) |
| DE (1) | DE60117701T2 (de) |
| WO (1) | WO2002052267A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0502497A (pt) * | 2005-06-28 | 2007-02-06 | Univ Minas Gerais | uso de agonistas e antagonistas do receptor acoplado a proteìna g, mas, como moduladores de atividade apoptótica para o estudo, a prevenção e o tratamento de doenças |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5017689A (en) * | 1989-07-06 | 1991-05-21 | Arizona Technology Development Corporation | Dynorphin analogs specific for kappa opioid receptors |
| SE9704836D0 (sv) | 1997-12-22 | 1997-12-22 | Astra Pharma Inc | Novel receptor |
-
2001
- 2001-12-19 WO PCT/SE2001/002854 patent/WO2002052267A1/en not_active Ceased
- 2001-12-19 EP EP01272423A patent/EP1346221B1/de not_active Expired - Lifetime
- 2001-12-19 CA CA002430719A patent/CA2430719A1/en not_active Abandoned
- 2001-12-19 JP JP2002553115A patent/JP2004516036A/ja active Pending
- 2001-12-19 AT AT01272423T patent/ATE320005T1/de not_active IP Right Cessation
- 2001-12-19 US US10/250,629 patent/US7078177B2/en not_active Expired - Fee Related
- 2001-12-19 DE DE60117701T patent/DE60117701T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ATE320005T1 (de) | 2006-03-15 |
| US20040171080A1 (en) | 2004-09-02 |
| CA2430719A1 (en) | 2002-07-04 |
| JP2004516036A (ja) | 2004-06-03 |
| EP1346221A1 (de) | 2003-09-24 |
| EP1346221B1 (de) | 2006-03-08 |
| WO2002052267A1 (en) | 2002-07-04 |
| US7078177B2 (en) | 2006-07-18 |
| DE60117701T2 (de) | 2006-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69835225D1 (de) | Methode zur behandlung von durch glycocorticoidstörungen verursachten psychosen | |
| ATE377606T1 (de) | Zyklische antagonisten der c5a rezeptoren sowie der g-protein gekoppelten rezeptoren | |
| EA200600773A1 (ru) | Антагонисты мускариновых ацетилхолиновых рецепторов | |
| DE60222396D1 (de) | N-(2-arylethyl) benzylamine als 5-ht6 rezeptor-antagoniste | |
| EA199800913A1 (ru) | Кальцилитические соединения | |
| PT1009732E (pt) | 1-amino-alquilciclo-hexanos antagonistas do receptor nmda | |
| DE60040212D1 (de) | Effiziente parallele prüfung von integrierten schaltungsvorrichtungen, unter verwendung einer bekannten guten schaltung, um erwartete antworten zu erzeugen | |
| EA199900630A1 (ru) | Антагонисты рецепторов витронектина | |
| GT200900187A (es) | Derivados de oxindol sustituido, medicamentos que los comprenden y uso los mismos | |
| ATE243993T1 (de) | Verwendung von 5ht3 antagonisten zum fördern der darmspülung | |
| EA200501724A1 (ru) | Соединения, специфичные к меланокортиновым рецепторам | |
| EA200300593A1 (ru) | Соединения пиперазинилпиразинов в качестве агонистов или антагонистов серотонин 5-ht2 рецептора | |
| DE50011178D1 (de) | Substituierte 1,5-dihydropyrrol-2-on-derivate wirksam als nmda-rezeptor-antagonisten für die behandlung von schmerzzuständen | |
| DE60121557D1 (de) | Metabolite von estrogen-agonisten/-antagonisten | |
| DE60114027D1 (de) | Verwendung von einem aldosteron-rezeptor-antagonisten zur verbesserung der kognitiven funktion | |
| IS5641A (is) | Azabísýklískir 5HT1 viðtaka bindlar | |
| ATE260278T1 (de) | 5ht1 rezeptor antagonisten und ihre verwendung für die behandlung von depression | |
| DE60117701D1 (de) | Testverfahren für agonisten oder antagonisten der bindung von dynorphin a an den mas-rezeptor | |
| DE60210989D1 (de) | Der ligand für den g-protein gekoppelten rezeptor gpr86 und seine verwendungen | |
| NO20006320L (no) | Cykliske somatostatin-analoger | |
| TR200002072T2 (tr) | Spiropiperidin türevleri | |
| DE69920436D1 (de) | Simulierte testverbindung zur untersuchung von drehschlagwerkzeugen | |
| ATE408144T1 (de) | Assays | |
| DE50015432D1 (de) | Prüfeinrichtung zum prüfen von langgestreckten gegenständen | |
| ATE426807T1 (de) | Proteomanalyse verfahren zum drogen vergleich |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |